| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 0.0007 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0007 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0009 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.001 |